About this trial
The purpose of this study is to clarify the biomarkers for rapid diagnosis and stratified diagnosis of severe respiratory tract infectious diseases through clinical experiments.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Meets the diagnostic criteria for severe pneumonia;
Age≥18 years old and < 80 years old;
Willing to sign informed consent for the course of the study;
Disqualifiers
Patients with intracranial hypertension, acute coronary syndrome, pleural fistula, pneumothorax, or subcutaneous emphysema;
Pregnant and lactating patients;
Severely hemodynamically unstable (an increase in vasopressors by more than 30% in the first 6 hours, or norepinephrine >0.5mg/kg/min);
Those who do not consent to participate in this study;
Trial population
Meets the diagnostic criteria for severe pneumonia;
Trial design
Cohort
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
The relationship between the patient's specific biomarker levels and clinical outcomes.
Treatment failure rate, Mortality rates, SOFA rating scale
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: